BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Venture Partner Mike Grey named EY Entrepreneur Of The Year San Diego
News | 06. 24. 2014
Venture Partner Mike Grey named EY Entrepreneur Of The Year San Diego
